DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1023/A:1006344010050, but it redirected us to https://link.springer.com/article/10.1023/A:1006344010050. The analysis below is for the second page.

Title[redir]:
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67 | Breast Cancer Research and Treatment
Description:
Proliferation indices are intended to help patients and clinicians make treatment decisions. We have previously demonstrated that a proliferation index based on in vivo labeling of S-phase cells with bromodeoxyuridine (BrdUrd) correlates with Ki-67 labeling index (LI). We now compare the prognostic value of these indices. With written consent, we gave 129 women with biopsy confirmed breast cancer 200 mg/M2 BrdUrd during 30 min immediately preceding surgery. We used IU-4 anti BrdUrd antibody to count the immunohistochemical labeling index (LI) of DNA-incorporated BrdUrd in 2,000 cells and MIB-1 to count Ki-67 (118 cases). Patients received standard surgical and adjuvant treatment. No patients were lost to follow-up and patients were followed a minimum of 2 (median 5.1) years. We compared survival and recurrence in tumors with high vs low labeling indices. We found that women in the low BrdUrd LI group had better disease free survival (92% vs 67% 5-yr DFS p = 0.001) and overall survival (94% vs 70% 5-yr OS, p = 0.0001) than those with a high LI. In comparison, a low Ki-67 index predicted better OS (87% vs 80% 5-yr OS, p = 0.020) and a trend for better DFS (84% vs 72% DFS p = 0.055). The apparent superiority of BrdUrd LI over Ki-67 LI is likely due to chance (p = 0.18). In multivariate survival analyses we found that BrdUrd LI proliferative index significantly improves prediction of DFS or OS even when node status, age or tumor size is in the model. We conclude that markers of proliferation are useful adjuncts in predicting patient prognosis.

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, breast, google, scholar, prognostic, proliferation, bromodeoxyuridine, labeling, index, human, article, vivo, cell, res, indices, moore, patients, sphase, brdurd, treat, clin, oncol, california, research, study, ljung, smith, dna, fraction, content, goodson, iii, chew, waldman, survival, comparison, tumor, growth, flow, usa, privacy, cookies, markers, access, cancers, kinetics, publish, search, treatment, mayall,

Topics {✒️}

disease free survival clinically negative lymph-nodes month download article/chapter cytofluorimetric s-phase fraction britt-marie ljung flow cytometric s-phase sentinel-node biopsy multivariate survival analyses predicting patient prognosis long-term prognosis privacy choices/manage cookies related subjects goodson wh iii primary breast cancers predictive factor operable breast cancer s-phase fraction s-phase cells human breast cancers primary breast carcinomas mammary carcinomas labeled cmf versus caf full article pdf low labeling indices nodenegative breast cancer human breast cancer invasive breast cancer breast cancer evaluated female breast cancer proliferation index based immunohistochemical labeling index g2-phase cells ten velde gpm ki-67 proliferation index ki-67 labeling index dna-incorporated brdurd tumor markers human ovarian cancer human bladder cancer bromodeoxyuridine labeling index tumor cell proliferation european economic area short-term recurrences avoid axillary dissection moore dh ii moore hd ii vitro bromodeoxyuridine labeling conditions privacy policy monoclonal antibody ki-67 3h thymidine labeling

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
         description:Proliferation indices are intended to help patients and clinicians make treatment decisions. We have previously demonstrated that a proliferation index based on in vivo labeling of S-phase cells with bromodeoxyuridine (BrdUrd) correlates with Ki-67 labeling index (LI). We now compare the prognostic value of these indices. With written consent, we gave 129 women with biopsy confirmed breast cancer 200 mg/M2 BrdUrd during 30 min immediately preceding surgery. We used IU-4 anti BrdUrd antibody to count the immunohistochemical labeling index (LI) of DNA-incorporated BrdUrd in 2,000 cells and MIB-1 to count Ki-67 (118 cases). Patients received standard surgical and adjuvant treatment. No patients were lost to follow-up and patients were followed a minimum of 2 (median 5.1) years. We compared survival and recurrence in tumors with high vs low labeling indices. We found that women in the low BrdUrd LI group had better disease free survival (92% vs 67% 5-yr DFS p = 0.001) and overall survival (94% vs 70% 5-yr OS, p = 0.0001) than those with a high LI. In comparison, a low Ki-67 index predicted better OS (87% vs 80% 5-yr OS, p = 0.020) and a trend for better DFS (84% vs 72% DFS p = 0.055). The apparent superiority of BrdUrd LI over Ki-67 LI is likely due to chance (p = 0.18). In multivariate survival analyses we found that BrdUrd LI proliferative index significantly improves prediction of DFS or OS even when node status, age or tumor size is in the model. We conclude that markers of proliferation are useful adjuncts in predicting patient prognosis.
         datePublished:
         dateModified:
         pageStart:113
         pageEnd:123
         sameAs:https://doi.org/10.1023/A:1006344010050
         keywords:
            breast cancer
            bromodeoxyuridine
            Ki-67
            nodes
            survival
            S-phase
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:59
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:William H. Goodson
               affiliation:
                     name:California Pacific Medical Research Institute
                     address:
                        name:Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dan H. Moore
               affiliation:
                     name:California Pacific Medical Center
                     address:
                        name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
                        type:PostalAddress
                     type:Organization
                     name:Departments of Epidemiology Biostatistics & Biostatistics
                     address:
                        name:Departments of Epidemiology Biostatistics & Biostatistics, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Britt-Marie Ljung
               affiliation:
                     name:University of California
                     address:
                        name:Department of Pathology, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karen Chew
               affiliation:
                     name:University of California
                     address:
                        name:Department of Pathology, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Brian Mayall
               affiliation:
                     name:University of California
                     address:
                        name:Laboratory Medicine, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Helene S. Smith
               affiliation:
                     name:California Pacific Medical Center
                     address:
                        name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frederic M. Waldman
               affiliation:
                     name:University of California
                     address:
                        name:Laboratory Medicine, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
      description:Proliferation indices are intended to help patients and clinicians make treatment decisions. We have previously demonstrated that a proliferation index based on in vivo labeling of S-phase cells with bromodeoxyuridine (BrdUrd) correlates with Ki-67 labeling index (LI). We now compare the prognostic value of these indices. With written consent, we gave 129 women with biopsy confirmed breast cancer 200 mg/M2 BrdUrd during 30 min immediately preceding surgery. We used IU-4 anti BrdUrd antibody to count the immunohistochemical labeling index (LI) of DNA-incorporated BrdUrd in 2,000 cells and MIB-1 to count Ki-67 (118 cases). Patients received standard surgical and adjuvant treatment. No patients were lost to follow-up and patients were followed a minimum of 2 (median 5.1) years. We compared survival and recurrence in tumors with high vs low labeling indices. We found that women in the low BrdUrd LI group had better disease free survival (92% vs 67% 5-yr DFS p = 0.001) and overall survival (94% vs 70% 5-yr OS, p = 0.0001) than those with a high LI. In comparison, a low Ki-67 index predicted better OS (87% vs 80% 5-yr OS, p = 0.020) and a trend for better DFS (84% vs 72% DFS p = 0.055). The apparent superiority of BrdUrd LI over Ki-67 LI is likely due to chance (p = 0.18). In multivariate survival analyses we found that BrdUrd LI proliferative index significantly improves prediction of DFS or OS even when node status, age or tumor size is in the model. We conclude that markers of proliferation are useful adjuncts in predicting patient prognosis.
      datePublished:
      dateModified:
      pageStart:113
      pageEnd:123
      sameAs:https://doi.org/10.1023/A:1006344010050
      keywords:
         breast cancer
         bromodeoxyuridine
         Ki-67
         nodes
         survival
         S-phase
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:59
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:William H. Goodson
            affiliation:
                  name:California Pacific Medical Research Institute
                  address:
                     name:Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dan H. Moore
            affiliation:
                  name:California Pacific Medical Center
                  address:
                     name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
                     type:PostalAddress
                  type:Organization
                  name:Departments of Epidemiology Biostatistics & Biostatistics
                  address:
                     name:Departments of Epidemiology Biostatistics & Biostatistics, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Britt-Marie Ljung
            affiliation:
                  name:University of California
                  address:
                     name:Department of Pathology, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karen Chew
            affiliation:
                  name:University of California
                  address:
                     name:Department of Pathology, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Brian Mayall
            affiliation:
                  name:University of California
                  address:
                     name:Laboratory Medicine, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Helene S. Smith
            affiliation:
                  name:California Pacific Medical Center
                  address:
                     name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frederic M. Waldman
            affiliation:
                  name:University of California
                  address:
                     name:Laboratory Medicine, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:59
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:California Pacific Medical Research Institute
      address:
         name:Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
         type:PostalAddress
      name:California Pacific Medical Center
      address:
         name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
         type:PostalAddress
      name:Departments of Epidemiology Biostatistics & Biostatistics
      address:
         name:Departments of Epidemiology Biostatistics & Biostatistics, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Pathology, University of California, San Francisco, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Pathology, University of California, San Francisco, USA
         type:PostalAddress
      name:University of California
      address:
         name:Laboratory Medicine, University of California, San Francisco, USA
         type:PostalAddress
      name:California Pacific Medical Center
      address:
         name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
         type:PostalAddress
      name:University of California
      address:
         name:Laboratory Medicine, University of California, San Francisco, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:William H. Goodson
      affiliation:
            name:California Pacific Medical Research Institute
            address:
               name:Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Dan H. Moore
      affiliation:
            name:California Pacific Medical Center
            address:
               name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
               type:PostalAddress
            type:Organization
            name:Departments of Epidemiology Biostatistics & Biostatistics
            address:
               name:Departments of Epidemiology Biostatistics & Biostatistics, USA
               type:PostalAddress
            type:Organization
      name:Britt-Marie Ljung
      affiliation:
            name:University of California
            address:
               name:Department of Pathology, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Karen Chew
      affiliation:
            name:University of California
            address:
               name:Department of Pathology, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Brian Mayall
      affiliation:
            name:University of California
            address:
               name:Laboratory Medicine, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Helene S. Smith
      affiliation:
            name:California Pacific Medical Center
            address:
               name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Frederic M. Waldman
      affiliation:
            name:University of California
            address:
               name:Laboratory Medicine, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Surgery, California Pacific Medical Research Institute, San Francisco, USA
      name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
      name:Departments of Epidemiology Biostatistics & Biostatistics, USA
      name:Department of Pathology, University of California, San Francisco, USA
      name:Department of Pathology, University of California, San Francisco, USA
      name:Laboratory Medicine, University of California, San Francisco, USA
      name:The Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, USA
      name:Laboratory Medicine, University of California, San Francisco, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(133)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

4.35s.